Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 379-391

  Singh, R A K ^a   Wu, L ^a   Barry, M A ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA; UBIQUITIN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION; VIRUS INFECTION;

EID: 0036134878     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.379     Document Type: Article

References (41)

1. HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
2. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
3. Autologous HIV-1 neutralizing antibodies: Emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies
4. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
5. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
6. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
7. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I sydrome
8. + lymphocytes
9. + T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine
10. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
11. Protective effects of a live attenuated SIV vaccine with a deletion of the nef gene
12. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine
13. mac251: Dependence on route of challenge exposure
14. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV
15. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
16. mac251
17. Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus
18. Gene inoculation generates immune responses against human immunodeficiency virus type 1
19. Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo
20. Use of DNAs expressing HIV-1 env and noninfectious HIV-1 particles to raise antibody responses in mice
21. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys
22. Development of a multicompartment candidate vaccine for HIV-1
23. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques
24. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
25. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
26. Protection from pathogenic SIV challenge using multigenic DNA vaccines
27. Prime-boost immunization strategies against HIV
28. Protection against mycoplasma infection using expression library immunization: A general approach to vaccine development
29. Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses
30. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
31. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
32. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase
33. Envelope protein and P18IIIB peptide recognized by vaccine-induced human cytolytic T cells
34. Dynamics of viral variants in HIV-1 nef and specific cytotoxic T lymphocytes in vivo
35. Phenotypic analysis of antigen-specific T lymphocytes
36. ELI's coming: Expression library immunization and vaccine antigen discovery
37. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
38. DNA-based immunization by in vivo transfection of dendritic cells
39. Genetic immunization with lung-targeting polyethyleneimine-macroaggregated albumin conjugates elicits combined systemic and mucosal immune responses
40. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
41. DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction